GW Canadian Fund (no longer available for sale)
A sample of the fund’s investments:
Targeted Growth Canada Inc.
Targeted Growth (TGI) is a privately-held crop biotechnology company with offices in Saskatoon and Seattle that is focused on developing products that target enhanced yield and improved quality for the agriculture and energy industries.
Cytochroma is a privately-held, clinical stage specialty pharmaceutical company that is headquartered in Markham and that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD).
BTI Systems Inc.
Headquartered in Ottawa with regional offices in Boston, Belfast, and Shanghai, as well as sales offices and industry-leading technology partners all around the
world, BTI is privately held and venture capital backed. BTI is committed to delivering best-in-class packet optical solutions to the global marketplace.
One Chip Photonics
OneChip Photonics is a privately held company, headquartered in Ottawa, that develops and manufactures low-cost, high-performance optical transceivers – based on monolithic Photonic Integrated Circuits (PICs) in Indium Phosphide (InP) – for access networks and other massmarket broadband applications.
Morega is a privately-held software and systems company headquartered in Toronto that provides innovative media mobility solutions for Multi-Channel Operators and Consumer Electronics OEMs.